These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1284753)

  • 41. Diagnostic fetal umbilical blood sampling in the management of isoimmunization.
    Reece EA; Copel JA; Scioscia AL; Grannum PA; DeGennaro N; Hobbins JC
    Am J Obstet Gynecol; 1988 Nov; 159(5):1057-62. PubMed ID: 3142263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evaluation of maternal anti-D concentrations during pregnancy.
    Filbey D; Berseus O; Sandström B; Wesström G
    Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of pregnancies complicated by anti-Kell isoimmunization.
    McKenna DS; Nagaraja HN; O'Shaughnessy R
    Obstet Gynecol; 1999 May; 93(5 Pt 1):667-73. PubMed ID: 10912964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
    Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
    Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
    Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
    Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience.
    Moncharmont P; Juron Dupraz F; Vignal M; Rigal D; Meyer F; Debeaux P
    Arch Gynecol Obstet; 1991; 248(4):175-80. PubMed ID: 1910321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IVIG - is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series.
    Connan K; Kornman L; Savoia H; Palma-Dias R; Rowlands S
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):612-8. PubMed ID: 20070709
    [No Abstract]   [Full Text] [Related]  

  • 50. Rh haemolytic disease: continuing problem of management.
    Swinhoe DJ; Gilmore DH; McNay MB; Whittle MJ
    Arch Dis Child; 1990 Apr; 65(4 Spec No):365-8. PubMed ID: 2110805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous umbilical blood sampling and umbilical vein transfusions. Rapid serologic differentiation of fetal blood from maternal blood.
    Steiner EA; Judd WJ; Oberman HA; Hayashi RH; Nugent CE
    Transfusion; 1990 Feb; 30(2):104-8. PubMed ID: 2305437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.
    Le Van Kim C; Mouro I; Brossard Y; Chavinié J; Cartron JP; Colin Y
    Br J Haematol; 1994 Sep; 88(1):193-5. PubMed ID: 7803243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced techniques for the treatment of severe isoimmunization.
    Vomund SL; Witter SE
    MCN Am J Matern Child Nurs; 1994; 19(1):18-23. PubMed ID: 8201857
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro assays to predict the severity of hemolytic disease of the newborn.
    Hadley AG
    Transfus Med Rev; 1995 Oct; 9(4):302-13. PubMed ID: 8541713
    [No Abstract]   [Full Text] [Related]  

  • 56. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
    Li P; Pang LH; Liang HF; Chen HY; Fan XJ
    Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reevaluation of the polyvinylpyrrolidone sedimentation test in the diagnosis of ABO hemolytic disease of the newborn.
    Shilo R; Gutman R; Ascari D; Schwartz J
    Vox Sang; 1976; 31(1 SUPPL):16-24. PubMed ID: 1007148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Feto-maternal alloimmunization].
    Thoumsin H
    Rev Med Liege; 1988 Nov; 43(22):743-5. PubMed ID: 3146792
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
    Gottvall T; Hildén JO; Selbing A
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.